bioXcelerate launches breakthrough AI tool for faster drug discovery

An­oth­er in­flam­ma­tion and im­munol­o­gy start­up has at­tract­ed big bucks. On Thurs­day, Evom­mune an­nounced a $115 mil­lion raise to back a pipeline an­tic­i­pat­ed to have mul­ti­ple

A bi­par­ti­san group of sen­a­tors in­tro­duced leg­is­la­tion on Thurs­day that aims to bol­ster do­mes­tic gener­ic man­u­fac­tur­ing in an ef­fort to shore up stock­piles of key